RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice
SARS-CoV-2에 대한 2개의 항원 소단위 단백질 백신 후보인 RelCoVax®는 마우스에서 강력한 면역 반응을 유도합니다
Article
[키워드] adjuvant
adjuvants
Administered
alum
aluminum
aluminum hydroxide
Antibody titer
Antibody titers
Antigen
antigen exposure
Cell
Cellular immune response
cellular immune responses
Combination
contribute
COVID-19 pandemic
CpG
Delta
delta variant
demonstrated
develop
dominant
dose regimen
dual
E. coli
effective vaccine
elicited
Emergency use authorization
evade
evidenced
glycoprotein
heterologous expression
hydroxide
IFN-γ
immune responses
immunize
immunized
immunized mice
in vitro
induce
mammalian cell
mammalian cells
mice
Mutation
N protein
N proteins
neutralize
Neutralizing antibodies
neutralizing antibody
nucleocapsid
prime and boost
Protein
RBD
Receptor binding domain
Region
RelCoVax®
S protein
Safe
SARS-CoV-2
SARS-CoV-2 viral
SARS-CoV-2 virus
serum
splenocyte
splenocytes
stimulated
strain
strong immune response
subunit
Subunit vaccine
Th1
the SARS-CoV-2 virus
vaccinated individuals
Vaccine
vaccine candidate
vaccine candidates
variants of SARS-CoV-2
viral strains
virus entry
[DOI] 10.1016/j.vaccine.2022.06.026 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.vaccine.2022.06.026 PMC 바로가기 [Article Type] Article